Natural Killer Cells Therapeutics Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 NK Cell Therapies
1.2.3 NK Cell Directed Antibodies
1.3 Market by Application
1.3.1 Global Natural Killer Cells Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Research Centers & Institutes
1.3.3 Hospitals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Natural Killer Cells Therapeutics Market Perspective (2017-2028)
2.2 Natural Killer Cells Therapeutics Growth Trends by Region
2.2.1 Natural Killer Cells Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Natural Killer Cells Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Natural Killer Cells Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Natural Killer Cells Therapeutics Market Dynamics
2.3.1 Natural Killer Cells Therapeutics Industry Trends
2.3.2 Natural Killer Cells Therapeutics Market Drivers
2.3.3 Natural Killer Cells Therapeutics Market Challenges
2.3.4 Natural Killer Cells Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Natural Killer Cells Therapeutics Players by Revenue
3.1.1 Global Top Natural Killer Cells Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Natural Killer Cells Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Natural Killer Cells Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Natural Killer Cells Therapeutics Revenue
3.4 Global Natural Killer Cells Therapeutics Market Concentration Ratio
3.4.1 Global Natural Killer Cells Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Natural Killer Cells Therapeutics Revenue in 2021
3.5 Natural Killer Cells Therapeutics Key Players Head office and Area Served
3.6 Key Players Natural Killer Cells Therapeutics Product Solution and Service
3.7 Date of Enter into Natural Killer Cells Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Natural Killer Cells Therapeutics Breakdown Data by Type
4.1 Global Natural Killer Cells Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Type (2023-2028)
5 Natural Killer Cells Therapeutics Breakdown Data by Application
5.1 Global Natural Killer Cells Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Natural Killer Cells Therapeutics Market Size (2017-2028)
6.2 North America Natural Killer Cells Therapeutics Market Size by Type
6.2.1 North America Natural Killer Cells Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Natural Killer Cells Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Natural Killer Cells Therapeutics Market Share by Type (2017-2028)
6.3 North America Natural Killer Cells Therapeutics Market Size by Application
6.3.1 North America Natural Killer Cells Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Natural Killer Cells Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Natural Killer Cells Therapeutics Market Share by Application (2017-2028)
6.4 North America Natural Killer Cells Therapeutics Market Size by Country
6.4.1 North America Natural Killer Cells Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Natural Killer Cells Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Natural Killer Cells Therapeutics Market Size (2017-2028)
7.2 Europe Natural Killer Cells Therapeutics Market Size by Type
7.2.1 Europe Natural Killer Cells Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Natural Killer Cells Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Natural Killer Cells Therapeutics Market Share by Type (2017-2028)
7.3 Europe Natural Killer Cells Therapeutics Market Size by Application
7.3.1 Europe Natural Killer Cells Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Natural Killer Cells Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Natural Killer Cells Therapeutics Market Share by Application (2017-2028)
7.4 Europe Natural Killer Cells Therapeutics Market Size by Country
7.4.1 Europe Natural Killer Cells Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Natural Killer Cells Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Natural Killer Cells Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Type
8.2.1 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Natural Killer Cells Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Application
8.3.1 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Natural Killer Cells Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region
8.4.1 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Natural Killer Cells Therapeutics Market Size (2017-2028)
9.2 Latin America Natural Killer Cells Therapeutics Market Size by Type
9.2.1 Latin America Natural Killer Cells Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Natural Killer Cells Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Natural Killer Cells Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Natural Killer Cells Therapeutics Market Size by Application
9.3.1 Latin America Natural Killer Cells Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Natural Killer Cells Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Natural Killer Cells Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Natural Killer Cells Therapeutics Market Size by Country
9.4.1 Latin America Natural Killer Cells Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Natural Killer Cells Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Natural Killer Cells Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Type
10.2.1 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Natural Killer Cells Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Application
10.3.1 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Natural Killer Cells Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country
10.4.1 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Affimed
11.1.1 Affimed Company Details
11.1.2 Affimed Business Overview
11.1.3 Affimed Natural Killer Cells Therapeutics Introduction
11.1.4 Affimed Revenue in Natural Killer Cells Therapeutics Business (2017-2022)
11.1.5 Affimed Recent Developments
11.2 Celgene Corporation
11.2.1 Celgene Corporation Company Details
11.2.2 Celgene Corporation Business Overview
11.2.3 Celgene Corporation Natural Killer Cells Therapeutics Introduction
11.2.4 Celgene Corporation Revenue in Natural Killer Cells Therapeutics Business (2017-2022)
11.2.5 Celgene Corporation Recent Developments
11.3 Fate Therapeutics
11.3.1 Fate Therapeutics Company Details
11.3.2 Fate Therapeutics Business Overview
11.3.3 Fate Therapeutics Natural Killer Cells Therapeutics Introduction
11.3.4 Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2017-2022)
11.3.5 Fate Therapeutics Recent Developments
11.4 Fortress Biotech
11.4.1 Fortress Biotech Company Details
11.4.2 Fortress Biotech Business Overview
11.4.3 Fortress Biotech Natural Killer Cells Therapeutics Introduction
11.4.4 Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business (2017-2022)
11.4.5 Fortress Biotech Recent Developments
11.5 Glycostem Therapeutics
11.5.1 Glycostem Therapeutics Company Details
11.5.2 Glycostem Therapeutics Business Overview
11.5.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Introduction
11.5.4 Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2017-2022)
11.5.5 Glycostem Therapeutics Recent Developments
11.6 Innate Pharma
11.6.1 Innate Pharma Company Details
11.6.2 Innate Pharma Business Overview
11.6.3 Innate Pharma Natural Killer Cells Therapeutics Introduction
11.6.4 Innate Pharma Revenue in Natural Killer Cells Therapeutics Business (2017-2022)
11.6.5 Innate Pharma Recent Developments
11.7 Nantkwest
11.7.1 Nantkwest Company Details
11.7.2 Nantkwest Business Overview
11.7.3 Nantkwest Natural Killer Cells Therapeutics Introduction
11.7.4 Nantkwest Revenue in Natural Killer Cells Therapeutics Business (2017-2022)
11.7.5 Nantkwest Recent Developments
11.8 Nkarta Therapeutics
11.8.1 Nkarta Therapeutics Company Details
11.8.2 Nkarta Therapeutics Business Overview
11.8.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Introduction
11.8.4 Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2017-2022)
11.8.5 Nkarta Therapeutics Recent Developments
11.9 NKT Therapeutics
11.9.1 NKT Therapeutics Company Details
11.9.2 NKT Therapeutics Business Overview
11.9.3 NKT Therapeutics Natural Killer Cells Therapeutics Introduction
11.9.4 NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2017-2022)
11.9.5 NKT Therapeutics Recent Developments
11.10 Ziopharm Oncology
11.10.1 Ziopharm Oncology Company Details
11.10.2 Ziopharm Oncology Business Overview
11.10.3 Ziopharm Oncology Natural Killer Cells Therapeutics Introduction
11.10.4 Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business (2017-2022)
11.10.5 Ziopharm Oncology Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of NK Cell Therapies
Table 3. Key Players of NK Cell Directed Antibodies
Table 4. Global Natural Killer Cells Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Natural Killer Cells Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Natural Killer Cells Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Natural Killer Cells Therapeutics Market Share by Region (2017-2022)
Table 8. Global Natural Killer Cells Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Natural Killer Cells Therapeutics Market Share by Region (2023-2028)
Table 10. Natural Killer Cells Therapeutics Market Trends
Table 11. Natural Killer Cells Therapeutics Market Drivers
Table 12. Natural Killer Cells Therapeutics Market Challenges
Table 13. Natural Killer Cells Therapeutics Market Restraints
Table 14. Global Natural Killer Cells Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Natural Killer Cells Therapeutics Revenue Share by Players (2017-2022)
Table 16. Global Top Natural Killer Cells Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cells Therapeutics as of 2021)
Table 17. Ranking of Global Top Natural Killer Cells Therapeutics Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Natural Killer Cells Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Natural Killer Cells Therapeutics Product Solution and Service
Table 21. Date of Enter into Natural Killer Cells Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Natural Killer Cells Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Natural Killer Cells Therapeutics Revenue Market Share by Type (2017-2022)
Table 25. Global Natural Killer Cells Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Natural Killer Cells Therapeutics Revenue Market Share by Type (2023-2028)
Table 27. Global Natural Killer Cells Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Natural Killer Cells Therapeutics Revenue Share by Application (2017-2022)
Table 29. Global Natural Killer Cells Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Natural Killer Cells Therapeutics Revenue Share by Application (2023-2028)
Table 31. North America Natural Killer Cells Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Natural Killer Cells Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Natural Killer Cells Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Natural Killer Cells Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Natural Killer Cells Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Natural Killer Cells Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Natural Killer Cells Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Natural Killer Cells Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Natural Killer Cells Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Natural Killer Cells Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Natural Killer Cells Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Natural Killer Cells Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Natural Killer Cells Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Natural Killer Cells Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Natural Killer Cells Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Natural Killer Cells Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Natural Killer Cells Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Natural Killer Cells Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Natural Killer Cells Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Natural Killer Cells Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Natural Killer Cells Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Natural Killer Cells Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Natural Killer Cells Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Natural Killer Cells Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Natural Killer Cells Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Natural Killer Cells Therapeutics Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Natural Killer Cells Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Natural Killer Cells Therapeutics Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Natural Killer Cells Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Natural Killer Cells Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 61. Affimed Company Details
Table 62. Affimed Business Overview
Table 63. Affimed Natural Killer Cells Therapeutics Product
Table 64. Affimed Revenue in Natural Killer Cells Therapeutics Business (2017-2022) & (US$ Million)
Table 65. Affimed Recent Developments
Table 66. Celgene Corporation Company Details
Table 67. Celgene Corporation Business Overview
Table 68. Celgene Corporation Natural Killer Cells Therapeutics Product
Table 69. Celgene Corporation Revenue in Natural Killer Cells Therapeutics Business (2017-2022) & (US$ Million)
Table 70. Celgene Corporation Recent Developments
Table 71. Fate Therapeutics Company Details
Table 72. Fate Therapeutics Business Overview
Table 73. Fate Therapeutics Natural Killer Cells Therapeutics Product
Table 74. Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2017-2022) & (US$ Million)
Table 75. Fate Therapeutics Recent Developments
Table 76. Fortress Biotech Company Details
Table 77. Fortress Biotech Business Overview
Table 78. Fortress Biotech Natural Killer Cells Therapeutics Product
Table 79. Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business (2017-2022) & (US$ Million)
Table 80. Fortress Biotech Recent Developments
Table 81. Glycostem Therapeutics Company Details
Table 82. Glycostem Therapeutics Business Overview
Table 83. Glycostem Therapeutics Natural Killer Cells Therapeutics Product
Table 84. Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2017-2022) & (US$ Million)
Table 85. Glycostem Therapeutics Recent Developments
Table 86. Innate Pharma Company Details
Table 87. Innate Pharma Business Overview
Table 88. Innate Pharma Natural Killer Cells Therapeutics Product
Table 89. Innate Pharma Revenue in Natural Killer Cells Therapeutics Business (2017-2022) & (US$ Million)
Table 90. Innate Pharma Recent Developments
Table 91. Nantkwest Company Details
Table 92. Nantkwest Business Overview
Table 93. Nantkwest Natural Killer Cells Therapeutics Product
Table 94. Nantkwest Revenue in Natural Killer Cells Therapeutics Business (2017-2022) & (US$ Million)
Table 95. Nantkwest Recent Developments
Table 96. Nkarta Therapeutics Company Details
Table 97. Nkarta Therapeutics Business Overview
Table 98. Nkarta Therapeutics Natural Killer Cells Therapeutics Product
Table 99. Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2017-2022) & (US$ Million)
Table 100. Nkarta Therapeutics Recent Developments
Table 101. NKT Therapeutics Company Details
Table 102. NKT Therapeutics Business Overview
Table 103. NKT Therapeutics Natural Killer Cells Therapeutics Product
Table 104. NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2017-2022) & (US$ Million)
Table 105. NKT Therapeutics Recent Developments
Table 106. Ziopharm Oncology Company Details
Table 107. Ziopharm Oncology Business Overview
Table 108. Ziopharm Oncology Natural Killer Cells Therapeutics Product
Table 109. Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business (2017-2022) & (US$ Million)
Table 110. Ziopharm Oncology Recent Developments
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Natural Killer Cells Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. NK Cell Therapies Features
Figure 3. NK Cell Directed Antibodies Features
Figure 4. Global Natural Killer Cells Therapeutics Market Share by Application: 2021 VS 2028
Figure 5. Research Centers & Institutes Case Studies
Figure 6. Hospitals Case Studies
Figure 7. Others Case Studies
Figure 8. Natural Killer Cells Therapeutics Report Years Considered
Figure 9. Global Natural Killer Cells Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Natural Killer Cells Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Natural Killer Cells Therapeutics Market Share by Region: 2021 VS 2028
Figure 12. Global Natural Killer Cells Therapeutics Market Share by Players in 2021
Figure 13. Global Top Natural Killer Cells Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cells Therapeutics as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Natural Killer Cells Therapeutics Revenue in 2021
Figure 15. North America Natural Killer Cells Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Natural Killer Cells Therapeutics Market Size Market Share by Type (2017-2028)
Figure 17. North America Natural Killer Cells Therapeutics Market Size Market Share by Application (2017-2028)
Figure 18. North America Natural Killer Cells Therapeutics Market Size Share by Country (2017-2028)
Figure 19. United States Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Natural Killer Cells Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Natural Killer Cells Therapeutics Market Size Market Share by Type (2017-2028)
Figure 23. Europe Natural Killer Cells Therapeutics Market Size Market Share by Application (2017-2028)
Figure 24. Europe Natural Killer Cells Therapeutics Market Size Share by Country (2017-2028)
Figure 25. Germany Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Natural Killer Cells Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Natural Killer Cells Therapeutics Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Natural Killer Cells Therapeutics Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Natural Killer Cells Therapeutics Market Size Share by Region (2017-2028)
Figure 35. China Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Natural Killer Cells Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Natural Killer Cells Therapeutics Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Natural Killer Cells Therapeutics Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Natural Killer Cells Therapeutics Market Size Share by Country (2017-2028)
Figure 45. Mexico Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Natural Killer Cells Therapeutics Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Natural Killer Cells Therapeutics Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Natural Killer Cells Therapeutics Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Natural Killer Cells Therapeutics Market Size Share by Country (2017-2028)
Figure 51. Turkey Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Natural Killer Cells Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Affimed Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2017-2022)
Figure 55. Celgene Corporation Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2017-2022)
Figure 56. Fate Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2017-2022)
Figure 57. Fortress Biotech Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2017-2022)
Figure 58. Glycostem Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2017-2022)
Figure 59. Innate Pharma Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2017-2022)
Figure 60. Nantkwest Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2017-2022)
Figure 61. Nkarta Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2017-2022)
Figure 62. NKT Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2017-2022)
Figure 63. Ziopharm Oncology Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Industry Market Size
